Active, not recruitingPhase 2NCT05002777
Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)
Studying Autoimmune hemolytic anemia, warm type
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sanofi
- Intervention
- rilzabrutinib(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2029
Study locations (27)
- The Oncology Institute of Hope & Innovation Site Number : 8400006, Cerritos, California, United States
- TOI Clinical Research LLC_ Cerritos_Investigational Site Number: 8400006, Cerritos, California, United States
- TOI Clinical Research LLC_Glendale_Investigational Site Number: 8400006, Glendale, California, United States
- TOI Clinical Research LLC_Long Beach_Investigational Site Number: 8400006, Long Beach, California, United States
- University of Southern California_Investigational Site Number: 8400009, Los Angeles, California, United States
- TOI Clinical Research LLC_Santa Ana_Investigational Site Number: 8400006, Santa Ana, California, United States
- The Lundquist Institute_Investigational Site Number: 8400005, Torrance, California, United States
- TOI Clinical Research LLC_ Whittier_Investigational Site Number: 8400006, Whittier, California, United States
- Georgetown University Hospital_Investigational Site Number: 8400003, Washington D.C., District of Columbia, United States
- Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002, Tamarac, Florida, United States
- Massachusetts General Hospital_Investigational Site Number: 8400001, Boston, Massachusetts, United States
- Hanush-Krankenhaus_Investigational Site Number: 0400001, Vienna, Austria
- Peking Union Medical College Hospital_Investigational Site Number: 1560002, Beijing, China
- Institute of hematology&blood diseases hospital_Investigational Site Number: 1560003, Tianjin, China
- Odense Universitetshospital Hæmatologisk Forskningsenhed_Investigational Site Number: 2080001, Odense, Denmark
- +12 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05002777 on ClinicalTrials.govOther trials for Autoimmune hemolytic anemia, warm type
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07039422Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From IanalumabNovartis Pharmaceuticals
- RECRUITINGEARLY PHASE1NCT07530380UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic AnemiaThe Second Hospital of Anhui Medical University
- RECRUITINGNANCT05925023Sirolimus in the Treatment of Refractory/Relapsed wAIHAPeking Union Medical College Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT05648968A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaNovartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE2NCT04657094Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic LeukemiaCity of Hope Medical Center